DSP107
An Open-label Phase Ib Study of DSP107 for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 36 patients (estimated)
- Sponsors
- Kahr Medical
- Tags
- Antimetabolites, BCL-2 Inhibitor, Hypomethylating Agents (HMA), CD137, CD47
- Trial Type
- Treatment
- Last Update
- 3 months ago
- SparkCures ID
- 1538
- NCT Identifier
- NCT04937166
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.